Author:
Gwaza Luther,Gordon John,Leufkens Hubert,Stahl Matthias,García-Arieta Alfredo
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. WHO Expert Committee on Pharmaceutical Preparations. Multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability. In: WHO Technical Report Series. 49th ed. Geneva: World Health Organization; 2015. p. 17–9.
2. Chow SC, Liu J. Meta-analysis for bioequivalence review. J Biopharm Stat. 1997;7(1):97–111.
3. Anderson S. Individual bioequivalence: a problem of switchability. Biopharm Rep. 1993;2(2):1–11.
4. Davit BM, Nwakama PE, Buehler GJ, Conner DP, Haidar SH, Patel DT, et al. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration. Ann Pharmacother. 2009;43(10):1583–97.
5. Maliepaard M, Hekster YA, Kappelle A, Van Puijenbroek EP, Elferink AJ, Welink J, et al. Requirements for generic anti-epileptic medicines: a regulatory perspective. J Neurol. 2009;256(12):1966–71.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献